Literature DB >> 22477331

Suppression of postoperative intimal hyperplasia of vein grafts with edaravone in rat models - a scanning electron microscope study.

Mitsuhiro Yamamura1, Yuji Miyamoto, Masataka Mitsuno, Hiroe Tanaka, Yasuhiko Kobayashi, Masaaki Ryomoto.   

Abstract

PURPOSE: Postoperative intimal hyperplasia, the most common cause of vein graft occlusion, is initiated by endothelial injury. In the present study, the mechanism by which the free radical scavenger edaravone (Radicut, Mitsubishi Tanabe Pharma Co, Japan) protects against endothelial injury in postoperative intimal hyperplasia was investigated.
METHODS: In 18 male Lewis rats, a right epigastric vein graft was interposed into the common femoral artery. Nine rats received a pre-operative intraperitoneal administration of edaravone (3.0 mg/kg, edaravone group) and the other nine rats received an equal volume of saline (saline group). After 1 h, five vein grafts from each group were treated with Verhoeff-van Gieson elastica stain and subjected to a histological examination. The other four vein grafts from each group were examined with an S-800 Hitachi scanning electron microscope (SEM) (Hitachi High-Technologies Co, Japan) at ×1000 magnification, as were three unoperated right epigastric veins (unoperated vein group). The endothelial areas of the vein grafts were measured using computerized planimetry of the SEM images (ImageJ version 1.37, National Institutes of Health, USA). The mean endothelial areas (%) were compared between the two groups.
RESULTS: Verhoeff-van Gieson elastica stain revealed no significant differences between the two groups. SEM showed that endothelial cells in the unoperated epigastric vein had a cobblestone-like appearance. In the saline group, the endothelial cells were comb-shaped and had adherent monocytes. In the edaravone group, however, the cobblestone-like appearance of endothelial cells was well preserved, with little monocyte adhesion. Moreover, the mean (± standard error of the mean) endothelial area was significantly higher in vein grafts from the edaravone group than in those from the saline group (74±1.8% versus 56±4.3%, P<0.05), and was similar to those in the unoperated epigastric veins (72±1.9%).
CONCLUSION: These findings show that endothelial injury is present soon after placement of the interposition graft. The authors believe that edaravone suppresses postoperative intimal hyperplasia by alleviating endothelial injury.

Entities:  

Year:  2007        PMID: 22477331      PMCID: PMC2733028          DOI: 10.1055/s-0031-1278269

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  6 in total

Review 1.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

2.  Long-term benefits of internal thoracic artery-coronary artery bypass in Japanese patients.

Authors:  S Kitamura; K Kawachi; S Taniguchi; T Kawata; S Kobayashi; H Nishioka; K Mizuguchi; K Niwaya; Y Kameda; H Sakaguchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-01

3.  Effects of MCI-186 (edaravone), a novel free radical scavenger, upon experimental atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Taka-aki Okabe; Chiharu Kishimoto; Kana Shimada; Toshinori Murayama; Masayuki Yokode; Toru Kita
Journal:  Circ J       Date:  2006-09       Impact factor: 2.993

4.  Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro.

Authors:  T Watanabe; I Morita; H Nishi; S Murota
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1988-07       Impact factor: 4.006

5.  The rate of re-endothelialization correlates inversely with the degree of the following intimal thickening in vein grafts. Electron microscopic and immunohistochemical studies.

Authors:  Y Shiokawa; M F Rahman; Y Ishii; K Sueishi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

6.  An ultrastructural study of progressive intimal hyperplasia in rat vein grafts.

Authors:  V K Stark; T F Warner; J R Hoch
Journal:  J Vasc Surg       Date:  1997-07       Impact factor: 4.268

  6 in total
  3 in total

1.  Edaravone protects against tissue damage in the lung and kidney induced by myonephropathic metabolic syndrome.

Authors:  Mitsuhiro Yamamura; Yuji Miyamoto; Masataka Mitsuno; Hiroe Tanaka; Masaaki Ryomoto
Journal:  Int J Angiol       Date:  2010

2.  Edaravone suppresses postoperative reperfusion injury in rat lower extremity: An immunohistological study.

Authors:  Mitsuhiro Yamamura; Yuji Miyamoto; Masataka Mitsuno; Toshihiro Ohata; Hiroe Tanaka; Yasuhiko Kobayashi; Masaaki Ryomoto; Yoshiteru Yoshioka
Journal:  Int J Angiol       Date:  2007

3.  Edaravone suppresses endothelial cell injury in vein grafts of a rat model.

Authors:  Mitsuhiro Yamamura; Masataka Mitsuno; Hiroe Tanaka; Yasuhiko Kobayashi; Shinya Fukui; Yuji Miyamoto
Journal:  Int J Angiol       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.